How digital pharmacies can expand access to specialized care
Even the most aggressive proponents of telehealth must concede that while technology can open the door to health care for some, it can also become an obstacle for others. “It’s …
Read MoreTag: pharmaceuticals
Opinion: Rather than turning its back on the QALY, pharma should collaborate on efforts to improve it
A key element in the long-simmering debate on reining in drug prices in the United States is how to ensure that prices are affordable, represent a sufficient reward to industry …
Read More
Opinion: To create value, pharma companies should prioritize innovation, not shareholders
Biogen announced its quarterly earnings on April 22 and revealed it had repurchased $600 million of its shares in the first quarter — a majority (78%) of its operating cash …
Read More
Opinion: Congress: stand up to the paper lobby and abolish outdated paper labeling for clinicians
There’s no place in health care for practices that fail to serve the best interests of patients and their clinicians. One such obsolete and harmful practice is providing outdated and …
Read More
Opinion: It’s time to get health care value assessment right
Trying to gauge the value of new drugs and devices is becoming increasingly important in the U.S. health care system, something that other countries have done explicitly for years. Pressure …
Read More
First-of-its-kind study pits psilocybin against a common antidepressant
Can psilocybin, the active ingredient in psychedelic mushrooms, match the depression-combatting capabilities of a commonly prescribed antidepressant? The first head-to-head comparison, conducted by scientists at the Center for Psychedelic Research …
Read More
Opinion: No evidence that patents slow access to vaccines
At this point in the exhausting and deadly Covid-19 pandemic, people around the globe are giving thanks for the multiple vaccines that have been produced and authorized in record time. …
Read More
Opinion: Money from opioid lawsuits is urgently needed now
Opioid companies are being forced to pay for their grave mistakes and misdeeds in helping fuel the overdose epidemic in the United States. The total in settlements — including Purdue …
Read More
José Baselga, renowned cancer researcher and AstraZeneca oncology R&D head, dies at 61
José Baselga, a storied oncology researcher and pharmaceutical executive whose discoveries helped pave the way for new breast cancer therapies, died Sunday at the age of 61. His death was …
Read More